1. MARKETS
  2. SECTOR : HEALTHCARE & MEDICAL EQUIPMENT SUPPLIERS
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. STAAR SURGICAL CO.
Staar Surgical Co.
XNAS: STAA
779.8K
XNAS Volume

XNAS 07 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Staar Surgical Co. quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Staar Surgical Co. share price target, revenues, EPS, net income and more

Staar Surgical Co. quarterly results: revenue, profit, and P&L – 13 quarter history

  • POSITIVE

    Quarterly Revenue Staar Surgical Co. Jun-2026 Quarterly Revenue is $94 Million which is growth of 111.0% YoY.

  • POSITIVE

    Quarterly Net Profit Staar Surgical Co. Jun-2026 Quarterly Net Profit is $8 Million which is growth of 147.9% YoY.

Staar Surgical Co., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
93.593.557.894.744.342.64988.69977.476.380.392.3
Cost Of Rev.
23.824.714.116.911.514.617.320.120.616.315.616.721.6
Gross Profit
69.768.943.777.932.82831.768.578.46160.763.670.7
⌄
59.651.554.753.457.562.759.662.866.563.350.357.362.1
Operating Profit
10.117.4-10.924.4-24.7-34.7-27.95.711.9-2.310.46.38.6
0.90.91.10.81.41.41.61.41.41.51.71.71.8
Profit Before Tax
118.2-20.718.8-25.9-54.5-30.313.210.3-2.213.76.88.5
Tax
33-2.39.9-9.1-0.33.93.231.161.92.4
⌄
8.15.2-18.38.9-16.8-54.2-34.2107.4-3.37.84.86.1
Diluted NI Avail to Com Stockholders Ann.
8.15.2-18.38.9-16.8-54.2-34.2107.4-3.37.84.86.1
Basic EPS
0.20.1-0.40.2-0.3-1.1-0.70.20.2-0.10.20.10.1
Diluted EPS After ExtraOrdinary
0.20.2-0.20.3-0.3-0.7-0.60.10.2-00.10.10.2
Number Of Shares End
50.349.949.849.649.549.349.349.249.148.948.848.648.4
Net Income Continuing Discontinued Operations
8.15.2-18.38.9-16.8-54.2-34.2107.4-3.37.84.86.1
Normalized Income
8.411.9-7.313.9-15.1-33.1-31.15.59.6-1.66.85.87.4
Interest Income
0.9-1.10.81.4-1.61.41.41.5---
Interest
-------------
Net Interest Income
0.90.91.10.81.41.41.61.41.41.51.71.71.8
EBIT
10.117.4-10.924.4-24.7-34.7-27.95.711.9-2.310.46.38.6
EBITDA
13.419.6-8.526.4-22.7-32.4-25.57.413.4-111.67.610.1
Reconciled Cost Of Rev.
23.824.714.116.911.514.617.320.120.616.315.616.721.6
Reconciled Depr.
3.32.22.4222.32.41.81.51.21.21.31.5
Profit From Continuing Operations
8.15.2-18.38.9-16.8-54.2-34.2107.4-3.37.84.86.1
Normalized EBITDA
13.930.23.933.2-20.1-11.2-21.31.516.51.310.3911.9
*All financials are in USD Million and price data in USD

Staar Surgical Co. competitor comparison and performance snapshot within industry

Staar Surgical Co. annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

  • NEGATIVE

    Annual Revenue Staar Surgical Co. Dec-2025 Annual Revenue is $239 Million which is growth of -23.7% YoY.

  • NEGATIVE

    Annual Net Profit Staar Surgical Co. Dec-2025 Annual Net Profit is $-80 Million which is growth of -298.1% YoY.

Staar Surgical Co., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-5.6%
7.9%
 239.4313.9322.4284.4230.5163.5150.212490.682.477.1
Cost Of Rev. Ann.
-2.2%
4.8%
79.45774.369.86151.845.138.232.426.324.124.4
Gross Profit Ann.
-6.5%
9%
260.2182.4239.6252.7223.4178.6118.411291.564.358.452.7
Operating Exp. Ann.
8.3%
15.4%
219.2228.4252.2224.6179.6145.3111.6100.184.967.97158.1
Operating Profit Ann.
-
-
41-46-12.628.143.833.36.811.96.6-3.6-12.7-5.3
22.5%
87.2%
3.74.65.972.5-00.210.2-0.1-0.1-0.1
Other Exp. Ann.
-
-
 -40.9-2.4-1.4-0.7-21.30.2-0.11.50.3-0.2
PBT Ann.
-
-
17.4-82.3-9.133.745.631.38.3136.6-2.3-12.4-5.6
Tax Ann.
-
-
13.5-1.811.212.46.86.82.4-11.7-0.2-0.30.9
⌄
-
-
3.8-80.5-20.221.438.824.55.914.15-2.1-12.1-6.5
Diluted NI Avail to Com Stockholders Ann.
-
-
3.8-80.5-20.221.438.824.55.914.15-2.1-12.1-6.5
EPS Ann.
-
-
 -1.6-0.40.40.80.50.10.30.1-0.1-0.3-0.2
Diluted EPS Ann.
-
-
 -1.6-0.40.40.80.50.10.30.1-0.1-0.3-0.2
Number Of Shares End
1.1%
1.5%
 49.849.348.848.247.746.244.744.241.240.638.8
Total Exp. Ann.
5.9%
12.7%
 285.4326.5294.3240.6197.1156.7138.3117.494.295.182.5
Net Income Continuing Discontinued Operations Ann.
-
-
3.8-80.5-20.221.438.824.55.914.15-2.1-12.1-6.5
Normalized Income Ann.
-
-
26.9-38.2-17.522.640.226.85.314.45.6-2.9-12-6
Interest Income Ann.
-
87.2%
 4.65.9---0.2---0.1
Interest Ann.
-
-
 ---------0.10.1
EBITDA Ann.
-
-
51-37.2-5.733.248.3379.915.69.1-0.3-9.4-3.1
Reconciled Cost Of Rev. Ann.
-2.2%
4.8%
79.45774.369.86151.845.138.232.426.324.124.4
Reconciled Depr. Ann.
24.6%
22.9%
108.76.95.14.53.63.13.72.53.42.92.4
Profit From Continuing Operations Ann.
-
-
3.8-80.5-20.221.438.824.55.914.15-2.1-12.1-6.5
Normalized EBITDA Ann.
-50.7%
-7.8%
81.26-235.15040916.19.9-1.1-9.3-2.1
*All financials are in USD Million and price data in USD
Total Rev. Ann.
1Y CHG
-23.7%
2Y CAGR
-13.8%
3Y CAGR
-5.6%
5Y CAGR
7.9%
7Y CAGR
9.9%
10Y CAGR
12%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-9.4%
2Y CAGR
0.8%
3Y CAGR
8.3%
5Y CAGR
15.4%
7Y CAGR
15.2%
10Y CAGR
14.7%
Operating Expenses Annual Cr is falling faster than historical averages.

Staar Surgical Co. balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

  • NEGATIVE

    Total Shareholders Fund Staar Surgical Co. Dec-2025 Total Shareholders Fund is $344 Million which is growth of -13.4% YoY.

  • NEGATIVE

    Total Assets Staar Surgical Co. Dec-2025 Total Assets is $452 Million which is growth of -11.4% YoY.

Staar Surgical Co., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
2.9%
11.9%
451.7509.5488.7414.9345.8257.4206.9167.367.965.463
⌄
9.1%
12.3%
107.5112.2102.782.787.260.24734.92527.524.1
⌄
1.2%
11.8%
344.2397.3386332.2258.6197.2159.9132.442.937.938.9
Total Capitalization Ann.
1.2%
11.8%
344.2397.3386332.2258.6197.2159.9132.442.937.938.9
Tangible Assets Ann.
-1.9%
9.8%
311.7395.6384.2330.2256.6195.2157.8130.440.935.736.4
Working Capital Ann.
-2.2%
6.8%
243297.6300.2260222.6175.2140.2123.834.828.831.2
Invested Capital Ann.
1.2%
11.6%
344.2397.3386332.2258.6198.6161.7136.247.442.243
Tangible Book Value Ann.
-1.9%
9.8%
311.7395.6384.2330.2256.6195.2157.8130.440.935.736.4
Borrowings Ann.
7.4%
28.9%
38.438.735.83132.110.89.55.36.36.84.7
Net Debt Ann.
-
-
-----------
Share Issued Ann.
1.1%
1.4%
49.849.348.848.247.746.544.844.241.440.739.9
Number Of Shares End
1.1%
1.5%
49.849.348.848.247.746.244.744.241.240.638.8
*All financials are in USD Million and price data in USD
Total Assets Ann.
1Y CHG
-11.3%
2Y CAGR
-3.9%
3Y CAGR
2.9%
5Y CAGR
11.9%
7Y CAGR
15.2%
10Y CAGR
21.8%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-2.6%
2Y CAGR
2.7%
3Y CAGR
9.8%
5Y CAGR
10.7%
7Y CAGR
13.8%
10Y CAGR
14.4%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-13.4%
2Y CAGR
-5.6%
3Y CAGR
1.2%
5Y CAGR
11.8%
7Y CAGR
14.6%
10Y CAGR
24.4%
Total ShareHolders Funds Annual is falling faster than historical averages.

Staar Surgical Co. ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

  • NEGATIVE

    Book Value Per Share Staar Surgical Co. Book Value Per Share is $7 which is growth of -11.3% YoY.

  • NEUTRAL

    ROE Staar Surgical Co. ROE is 0% which is growth of 0% YoY.

Staar Surgical Co., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--4.05%4.72%10.19%8.12%2.55%7.51%4.22%-3.21%-18.89%-10.72%
ROE Ann. %
-
-
--5.16%5.94%13.12%10.75%3.31%9.61%5.67%-5.29%-31.61%-17.20%
ROIC %
-
-
--7.61.91.61.81.73.90.8-0.3-0.3-1.9
OPM Ann. %
-
-
-19.19%-4.02%8.71%15.40%14.47%4.14%7.89%5.32%-4.01%-15.35%-6.92%
Inventory Turnover Ratio Ann.
-
-
-1.92.42.92.92.62.32.21.91.61.5
Asset Turnover Ann. %
-
-
-0.60.70.80.80.70.81.11.41.31.3
Working Capital Turnover Ann.
-3.1%
2.1%
11.11.11.110.91.112.62.92.5
Quick Ratio Ann.
-
-
-4.44.95.45.14.64.44.821.51.7
Current Ratio Ann.
-
-
-5.25.665.65.35.15.52.82.42.7
Interest Coverage Ratio Ann.
-
-
----------107.2-42.8
LT Debt To Equity Ann.
-
-
-0.10.10.10.100000
*All financials are in USD Million and price data in USD

Staar Surgical Co. cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

  • NEGATIVE

    Cash From Operating Activity Staar Surgical Co. Dec-2025 Cash From Operating Activity is $-34 Million which is growth of -317.7% YoY.

  • POSITIVE

    Net Cash Flow Staar Surgical Co. Dec-2025 Net Cash Flow is $8 Million which is growth of 120.0% YoY.

Staar Surgical Co., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
-
-
-34.215.714.635.7442125.812.82.91.1-2.2
-
-
46.3-59.274.4-156.4-13.6-8.4-10.2-2.2-1.1-3.2-2
-
-
-4.65.77.48.317.819.60.274.62.434.6
Cash Plus Cash Eqv. End Of Year Ann.
21%
0.1%
153.2144.218386.5199.7152.512010418.61413.4
Net Increase In Cash Plus Cash Eqv.s Ann.
-
-25%
7.6-37.896.4-112.448.132.115.885.24.20.80.4
Cash Plus Cash Eqv. Begin Of Year Ann.
-10.3%
3.7%
144.218386.5199.7152.512010418.614.113.413
Income Tax Paid Supplemental Data Ann.
-
-
-112.86.6-------
Interest Paid Supplemental Data Ann.
0%
-
0.10.10.10.1-------
Capex Ann.
-
-
-5.8-23.4-18.2-18.1-13.6-8.4-10.2-2.3-1.1-3.2-2
Issuance Of Capital Stock Ann.
-
-
72.2
Issuance Of Debt Ann.
-
-
--------1.6-
Repayment Of Debt Ann.
-
-
-0-0.2-0.2-0.1-1.7-1.1-3.3-2.7-1.3-0.4-0.4
Repurchase Of Capital Stock Ann.
-
-
-8-1.5-2.1----0.1-0.2-0.6-
Free Cash Flow Ann.
-
-
-40.1-7.7-3.617.630.312.615.610.51.8-2.2-4.2
*All financials are in USD Million and price data in USD
Cash from Investing Act. Ann.
2Y CAGR
-21.1%
Cash from Investing Activity Annual growth is stable compared to historical averages.